[1]
R. KHAN, A. MASOOD, S. KHAN, A. MASOOD, . ABDULMANAN, and A. ZULFIQAR, “DOCETAXEL VERSUS DOCETAXEL PLUS CAPECITABINE AS NEOADJUVANT CHEMOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER PATIENTS”, Biol Clin Sci Res J, vol. 2024, no. 1, p. 654, Jan. 2024.